Another Look at the Results of the JUPITER Trial

C. Tissa Kappagoda, Ezra A Amsterdam

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) was a placebo-controlled trial undertaken on "apparently healthy" subjects selected primarily on the basis of high-sensitivity C-reactive protein concentrations ≥2.0 mg/L. JUPITER showed that rosuvastatin reduced the incidence of cardiac events compared to a control group. The study population (median age 66 years) included men and women with the metabolic syndrome (about 41%), median blood pressures in the prehypertensive range, current smoking (about 15%), median body mass indexes higher than normal, and Framingham 10-year risk >10% (about 50%). The presence of these risk factors indicates that a significant proportion of subjects were not "healthy" and warranted aggressive management under current guidelines, without the measurement of high-sensitivity C-reactive protein. Furthermore, <17% of the trial participants were taking guidelines-recommended aspirin, and 25% had systolic blood pressures >145 mm Hg and would have merited treatment for hypertension. It is likely that many of the participants did not receive care consistent with current standards. Thus, the benefit of statin therapy would have been more difficult to demonstrate if standard therapeutic recommendations had been followed. In conclusion, these considerations cast doubt on the contention that statin therapy should be initiated in apparently healthy individuals on the basis of elevated high-sensitivity C-reactive protein levels.

Original languageEnglish (US)
Pages (from-to)1603-1605
Number of pages3
JournalAmerican Journal of Cardiology
Issue number11
StatePublished - Dec 1 2009

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Another Look at the Results of the JUPITER Trial'. Together they form a unique fingerprint.

Cite this